These findings allow us to speculate the use of skin biopsy as an alternative less invasive method to assess the amount of CAPN3 protein when molecular diagnosis turn out to be inconclusive and the hypothesis of calpainopathy is strong. Here, CAPN3 is linked to autosomal recessive limb-girdle muscular dystrophy type 2A.